TY - JOUR
T1 - A novel dense CO2 supercritical fluid technology for the development
of microparticulate delivery systems containing ketoprofen
AU - SEGALE, Lorena
AU - MANNINA, PAOLO
AU - GIOVANNELLI, Lorella
AU - Danan, H
AU - Esposito, P
AU - Galli, L
AU - PATTARINO, Franco
PY - 2012
Y1 - 2012
N2 - VarioSol is an innovative, solvent-free technology able to produce microparticles exploiting near-critical
CO2 properties as spraying and cooling agent. The aim of the present work was to evaluate the feasibility
to produce in a single processing step by VarioSol technology, oral ketoprofen-loaded microparticles
with gastro-protective properties. The obtained products were powders composed of regular in shape
and small in diameter microparticles, characterized by high drug content (40%) and good flow properties.
Microparticles were composed by anionic lipids scarcely soluble at acidic pH, blended with gastro-resistant
polymers of the methacrylate type. In vitro drug release results indicated that the drug was rapidly
delivered from the microparticulate systems in phosphate buffer at pH 6.8, while in acidic medium, the
microparticles were able to retard the drug release process but without reaching complete gastro-resistance.
However, the results obtained in this study, although non optimal, are not far from the specifications
required for gastro-resistant release products (i.e., no more than 10% drug released after 1 h at pH 1.0)
according to EMA guidelines and represent a good starting point for future formulation development.
AB - VarioSol is an innovative, solvent-free technology able to produce microparticles exploiting near-critical
CO2 properties as spraying and cooling agent. The aim of the present work was to evaluate the feasibility
to produce in a single processing step by VarioSol technology, oral ketoprofen-loaded microparticles
with gastro-protective properties. The obtained products were powders composed of regular in shape
and small in diameter microparticles, characterized by high drug content (40%) and good flow properties.
Microparticles were composed by anionic lipids scarcely soluble at acidic pH, blended with gastro-resistant
polymers of the methacrylate type. In vitro drug release results indicated that the drug was rapidly
delivered from the microparticulate systems in phosphate buffer at pH 6.8, while in acidic medium, the
microparticles were able to retard the drug release process but without reaching complete gastro-resistance.
However, the results obtained in this study, although non optimal, are not far from the specifications
required for gastro-resistant release products (i.e., no more than 10% drug released after 1 h at pH 1.0)
according to EMA guidelines and represent a good starting point for future formulation development.
UR - https://iris.uniupo.it/handle/11579/33526
U2 - 10.1016/j.ejpb.2012.08.003
DO - 10.1016/j.ejpb.2012.08.003
M3 - Article
SN - 0939-6411
VL - 82
SP - 491
EP - 497
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
IS - 3
ER -